Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/27/26 16:57 | 3/25/26 | ELVN | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | 3 | S.d | -2,721 | 30.23 | 0 | -90 | 25 | D | |||||||||||||||
3/10/26 18:15 | 3/6/26 | ELVN | Health | Drug | Pharmaceutical Preparations | Hohl Benjamin | CO | O | CFO | 17 | S.dm | -1,268 | 22.75 | 0 | -56 | 51 | D | |||||||||||||||
2/19/26 18:38 | 2/17/26 | ELVN | Health | Drug | Pharmaceutical Preparations | Heyman Richard A. | CO | D | 3 | S.m | -413 | 25.24 | 0 | -16 | 173 | I | ||||||||||||||||
2/10/26 18:12 | 2/6/26 | ELVN | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | O | CHIEF SC | 17 | S.m | -6,557 | 23.84 | 0 | -275 | 1,003 | I | |||||||||||||||
1/13/26 17:54 | 1/9/26 | ELVN | Health | Drug | Pharmaceutical Preparations | Patel Anish | CO | O | COO | 13 | S.d | -3,484 | 23.23 | 0 | -150 | 337 | I | |||||||||||||||
11/19/25 18:45 | 11/17/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Kintz Samuel | CO | DO | P,CEO | 14 | S.m | -2,320 | 20.62 | 0 | -113 | 990 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |